These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12144683)

  • 41. Benign uterine mass-discrimination from leiomyosarcoma by a preoperative risk score: a multicenter cohort study.
    Köhler G; Vollmer M; Nath N; Hessler PA; Dennis K; Lehr A; Köller M; Riechmann C; Bralo H; Trojnarska D; Lehnhoff H; Krichbaum J; Krichbaum M; Evert K; Evert M; Zygmunt M; Kaderali L
    Arch Gynecol Obstet; 2019 Dec; 300(6):1719-1727. PubMed ID: 31677088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of magnetic resonance imaging in predicting efficacy of GnRH analogue treatment for uterine leiomyoma.
    Takahashi K; Okada M; Imaoka I; Sugimura K; Miyazaki K
    Hum Reprod; 2001 Sep; 16(9):1989-94. PubMed ID: 11527910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
    Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
    PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EMMPRIN (CD147) Expression in Smooth Muscle Tumors of the Uterus.
    Kefeli M; Yildiz L; Gun S; Ozen FZ; Karagoz F
    Int J Gynecol Pathol; 2016 Jan; 35(1):1-7. PubMed ID: 26352545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Limited-sequence magnetic resonance imaging in the evaluation of the ultrasonographically indeterminate pelvic mass.
    Chang SD; Cooperberg PL; Wong AD; Llewellyn PA; Bilbey JH
    Can Assoc Radiol J; 2004 Apr; 55(2):87-95. PubMed ID: 15131929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review.
    Sparić R; Andjić M; Babović I; Nejković L; Mitrović M; Štulić J; Pupovac M; Tinelli A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of Clinical Parameters and Multiparametric MRI as Predictive Factors for Differentiating Uterine Sarcoma From Atypical Leiomyoma.
    Bi Q; Xiao Z; Lv F; Liu Y; Zou C; Shen Y
    Acad Radiol; 2018 Aug; 25(8):993-1002. PubMed ID: 29422425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What MRI features suspect malignant pure mesenchymal uterine tumors rather than uterine leiomyoma with cystic degeneration?
    Kim TH; Kim JW; Kim SY; Kim SH; Cho JY
    J Gynecol Oncol; 2018 May; 29(3):e26. PubMed ID: 29400019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review.
    Yanai H; Wani Y; Notohara K; Takada S; Yoshino T
    Pathol Int; 2010 Jul; 60(7):506-9. PubMed ID: 20594271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dedifferentiated leiomyosarcoma of the uterus: a clinicopathologic and immunohistochemical analysis of 23 cases.
    Chapel DB; Maccio L; Bragantini E; Zannoni GF; Quade BJ; Parra-Herran C; Nucci MR
    Histopathology; 2023 May; 82(6):812-825. PubMed ID: 36704944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
    Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
    Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?].
    Leung F; Terzibachian JJ; Gay C; Chung Fat B; Aouar Z; Lassabe C; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 Feb; 37(2):109-14. PubMed ID: 19200764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment?
    DeMulder D; Ascher SM
    AJR Am J Roentgenol; 2018 Dec; 211(6):1405-1415. PubMed ID: 30354268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.
    Matsuura K; Inoue K; Hoshino E; Yasuda M; Hasegawa K; Okada Y; Baba Y; Kozawa E
    Jpn J Radiol; 2022 Apr; 40(4):385-395. PubMed ID: 34750737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with the histopathology.
    Kang BC; Kim JH; Kim KW; Lee DY; Baek SY; Lee SW; Jung WH
    Abdom Imaging; 2000; 25(1):14-24. PubMed ID: 10652915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study.
    Skorstad M; Kent A; Lieng M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1228-1234. PubMed ID: 27564388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
    Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.